Bixiye
P30-16 New Prior Authorization Requirement for Lyme Disease: Diagnostic Testing and Intravenous Antibiotic Therapy
Taariikhda dhaqangalka Barnaamijka: Jul 07, 2016
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2961 - 2970 ee natiijooyinka 3607
Bixiye
P14-16 Addition of Lazanda ® to Existing Drug-Related Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Mar 29, 2016
Bixiye
P49-16 New Drug-Related Prior Authorization Criteria with Quantity Limit for Zavesca
Taariikhda uu dhaqangalayo barnaamijka: Okt 27, 2016
Bixiye
P24-16 Providers will see a change in our Prior Authorization Process for Government Products
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2016
Bixiye
P7-16 Addition of Drugs to the Self-Administered Oral Oncology Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Jan 27, 2016
Bixiye
P5-17 Updated: Third Party Payments of Premium and/or Cost-Sharing
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2017
Bixiye
P8-16 Personal Care Assistance (PCA) Service UMPI Delay Process
Taariikhda uu dhaqangalayo Barnaamijka: 08, Feb 2016
Bixiye
P28R2-16 Revised: Elimination of Prior Authorization Requirements for Select Services for Government Programs
Taariikhda barnaamijka Dhaqangalayso Agosto 09, 2016
Bixiye
P26-16 Update to Billing Guidelines for Refence and Outside Lab Services for Minnesota Health Care Programs (MHCP) Subscribers
Taariikhda wax ku ool ah ee barnaamijka: Jun 07, 2016
Bixiye
P7-17 Drug-Related Prior Authorization for Growth Hormone
Taariikhda uu dhaqangalayo Barnaamijka: Mar 06, 2017